BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maan R, de Knegt RJ, Veldt BJ. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies. Drugs 2015;75:1981-92. [PMID: 26501978 DOI: 10.1007/s40265-015-0480-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Bankston PC, Al-Horani RA. New small molecule drugs for thrombocytopenia: chemical, pharmacological, and therapeutic use considerations. Int J Mol Sci. 2019;20:3013. [PMID: 31226783 DOI: 10.3390/ijms20123013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
2 Moore AH. Thrombocytopenia in Cirrhosis: A Review of Pathophysiology and Management Options. Clin Liver Dis (Hoboken) 2019;14:183-6. [PMID: 31879561 DOI: 10.1002/cld.860] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
3 Sato S, Miyake T, Kataoka M, Isoda K, Yazaki T, Tobita H, Ishimura N, Kinoshita Y. Efficacy of repeated lusutrombopag administration for thrombocytopenia in a patient scheduled for invasive hepatocellular carcinoma treatment. Intern Med. 2017;56:2887-2890. [PMID: 28943563 DOI: 10.2169/internalmedicine.8791-16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
4 Lin YY, Hu CT, Sun DS, Lien TS, Chang HH. Thioacetamide-induced liver damage and thrombocytopenia is associated with induction of antiplatelet autoantibody in mice. Sci Rep 2019;9:17497. [PMID: 31767905 DOI: 10.1038/s41598-019-53977-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
5 Lambert MP. Platelets in liver and renal disease. Hematology Am Soc Hematol Educ Program. 2016;2016:251-255. [PMID: 27913488 DOI: 10.1182/asheducation-2016.1.251] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
6 Biswas S, Vaishnav M, Pathak P, Gunjan D, Mahapatra SJ, Kedia S, Rout G, Thakur B, Nayak B, Kumar R, Shalimar. Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease. World J Hepatol 2022; 14(7): 1421-1437 [DOI: 10.4254/wjh.v14.i7.1421] [Reference Citation Analysis]
7 Anjum V, Arora P, Ansari SH, Najmi AK, Ahmad S. Antithrombocytopenic and immunomodulatory potential of metabolically characterized aqueous extract of Carica papaya leaves. Pharm Biol 2017;55:2043-56. [PMID: 28836477 DOI: 10.1080/13880209.2017.1346690] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
8 Flick AC, Ding HX, Leverett CA, Kyne RE, Liu KK-, Fink SJ, O’donnell CJ. Synthetic Approaches to the New Drugs Approved During 2015. J Med Chem 2017;60:6480-515. [DOI: 10.1021/acs.jmedchem.7b00010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 42] [Article Influence: 12.4] [Reference Citation Analysis]
9 Flores B, Trivedi HD, Robson SC, Bonder A. Hemostasis, bleeding and thrombosis in liver disease. J Transl Sci 2017;3. [PMID: 30221012 DOI: 10.15761/JTS.1000182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
10 Liang C, Takahashi K, Furuya K, Ohkohchi N, Oda T. Dualistic role of platelets in living donor liver transplantation: Are they harmful? World J Gastroenterol 2022; 28(9): 897-908 [DOI: 10.3748/wjg.v28.i9.897] [Reference Citation Analysis]
11 Nilles KM, Caldwell SH, Flamm SL. Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists. Hepatol Commun 2019;3:1423-34. [PMID: 31701067 DOI: 10.1002/hep4.1423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
12 Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia. Gastroenterology. 2018;155:705-718. [PMID: 29778606 DOI: 10.1053/j.gastro.2018.05.025] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 19.8] [Reference Citation Analysis]
13 Nilles KM, Flamm SL. Thrombocytopenia in Chronic Liver Disease: New Management Strategies. Clin Liver Dis 2020;24:437-51. [PMID: 32620282 DOI: 10.1016/j.cld.2020.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lu J, Jamieson BD, Hui AM. Avatrombopag ethnic sensitivity analysis in chronic liver disease and thrombocytopenia patients: individual-level pooled analysis. Therap Adv Gastroenterol 2022;15:17562848221105976. [PMID: 35795378 DOI: 10.1177/17562848221105976] [Reference Citation Analysis]
15 Shirley M, McCafferty EH, Blair HA. Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure. Drugs 2019;79:1689-95. [PMID: 31529283 DOI: 10.1007/s40265-019-01197-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Barnett CL, Mladsi D, Vredenburg M, Aggarwal K. Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures. Journal of Medical Economics 2018;21:827-34. [DOI: 10.1080/13696998.2018.1490301] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
17 Wang B, Chen F, Zhou Q, Zhou Y, Meng D, Geng P, Hua A, Ji W, Wang C, Wang S, Hu L. Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS. Int J Anal Chem 2020;2020:7290470. [PMID: 32550846 DOI: 10.1155/2020/7290470] [Reference Citation Analysis]
18 Kim ES. Lusutrombopag: First Global Approval. Drugs. 2016;76:155-158. [PMID: 26666417 DOI: 10.1007/s40265-015-0525-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
19 Song JC, Liu SY, Zhu F, Wen AQ, Ma LH, Li WQ, Wu J; Critical Care Medicine Committee of Chinese People’s Liberation Army (PLA); Chinese Society of Laboratory Medicine, Chinese Medical Association. Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China. Mil Med Res 2020;7:15. [PMID: 32241296 DOI: 10.1186/s40779-020-00244-w] [Reference Citation Analysis]
20 Hyslip J, Martins PN. Liver Repair and Regeneration in Transplant: State of the Art. Curr Transpl Rep 2020;7:90-8. [DOI: 10.1007/s40472-020-00269-z] [Reference Citation Analysis]
21 Osawa M, Akiyama H, Mae S, Fujiwara Y, Yamane M. Leukemic mature B-cell neoplasm observed during the treatment with romiplostim in patient with thrombocytopenia and liver cirrhosis. Clin Case Rep 2018;6:1087-9. [PMID: 29881570 DOI: 10.1002/ccr3.1530] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Nishida Y, Kawaoka T, Imamura M, Namba M, Fujii Y, Uchikawa S, Ohya K, Daijo K, Teraoka Y, Morio K, Fujino H, Nakahara T, Yamauchi M, Hiramatsu A, Tsuge M, Aikata H, Takahashi S, Hayes CN, Fukuhara T, Tsuji K, Arataki K, Nagaoki Y, Aisaka Y, Kamada K, Kodama H, Chayama K. Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures. Intern Med 2021;60:829-37. [PMID: 33087674 DOI: 10.2169/internalmedicine.5930-20] [Reference Citation Analysis]
23 Lin CH, Ho CM, Wu CH, Liang PC, Wu YM, Hu RH, Lee PH, Ho MC. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis. Surg Endosc 2020;34:5566-73. [PMID: 31993821 DOI: 10.1007/s00464-019-07357-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Armstrong N, Büyükkaramikli N, Penton H, Riemsma R, Wetzelaer P, Huertas Carrera V, Swift S, Drachen T, Raatz H, Ryder S, Shah D, Buksnys T, Worthy G, Duffy S, Al M, Kleijnen J. Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis. Health Technol Assess 2020;24:1-220. [PMID: 33108266 DOI: 10.3310/hta24510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Abdela J. Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag. Clin Med Insights Blood Disord 2019;12:1179545X19875105. [PMID: 31673229 DOI: 10.1177/1179545X19875105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Qureshi K, Patel S, Meillier A. The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence. Int J Hepatol 2016;2016:1802932. [PMID: 27800187 DOI: 10.1155/2016/1802932] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
27 Takahashi K, Liang C, Oda T, Ohkohchi N. Platelet and liver regeneration after liver surgery. Surg Today. 2020;50:974-983. [PMID: 31720801 DOI: 10.1007/s00595-019-01890-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Saab S, Bernstein D, Hassanein T, Kugelmas M, Kwo P. Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure. J Clin Gastroenterol 2020;54:503-11. [PMID: 32195771 DOI: 10.1097/MCG.0000000000001338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Poordad F, Terrault NA, Alkhouri N, Tian W, Allen LF, Rabinovitz M. Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies. Int J Hepatol 2020;2020:5421632. [PMID: 32047671 DOI: 10.1155/2020/5421632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]